16:35 EDT TuHURA Biosciences (HURA) files to sell 4.76M shares of common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HURA:
- TuHURA Biosciences included in Russell 3000 and 2000 Indexes
- TuHURA Biosciences Completes Acquisition of Kineta, Inc.
- TuHURA Biosciences Increases Authorized Common Stock Shares
- Buy Rating for TuHURA Biosciences: Promising Phase 3 Study and Strategic Merger with Kineta Inc.
- TuHURA Biosciences initiates Phase 3 approval trial of IFx-2.0 in carcinoma